Brief considerations about civil liability coming from genetic damage from CRISPR-Cas9
Main Article Content
Abstract
Biotechnology has been advancing at a speed inversely proportional to the evolution of the law. Linked to technological advances is the increase in cases of highly complex diseases, understood as those for which science hasn’t presented a cure or means of treatment. In this field is the use of the genetic engineering technique called CRISPR-Cas-9. With this context in mind, the research problem arises regarding civil liability resulting from genetic damage resulting from tests involving biotechnology, given the lack of specific regulations. Besides this, through the deductive research method, a doctrinal analysis will be carried out with a view to substantiating the application of objective civil liability in the event of genetic damage.
Downloads
Download data is not yet available.
Article Details
How to Cite
ESPOLADOR, Rita de Cássia Resquetti Tarifa; CORRÊA, Daniel Marinho; TREVISAN, Lucas Mendonça. Brief considerations about civil liability coming from genetic damage from CRISPR-Cas9. Revista IBERC, Belo Horizonte, v. 8, n. 1, p. 114–135, 2025. DOI: 10.37963/iberc.v8i1.334. Disponível em: https://revista.iberc.org.br/iberc/article/view/334. Acesso em: 10 may. 2026.
Section
National Doctrine